QIAamp Viral RNA Mini Kit

For isolation of viral RNA from cell-free body fluids

Features

Rapid isolation of high-quality, ready-to-use RNA
No organic extraction or alcohol precipitation
Consistent, high yields
Complete removal of contaminants and inhibitors

Useful Resources

QIAamp Viral RNA Mini Handbook Isolation of viral RNA from stool using the QIAamp® Viral RNA Mini Kit - (EN) For manual purification of SBV RNA from bull semen - (EN)

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

Buffer AVE (108 x 2 ml)

Cat. No. / ID: 1020953

Buffer AVE for elution of RNA

$492.00

Quantity

The QIAamp Viral RNA Mini Kit is intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.

✓ 24/7 automatic processing of online orders

✓ Knowledgeable and professional Product & Technical Support

✓ Fast and reliable (re)-ordering

Product Details

The QIAamp Viral RNA Mini Kit simplifies purification of viral RNA from cell-free body fluids with fast spin-column or vacuum procedures. Viral RNA binds specifically to the QIAamp silica membrane, and pure viral RNA is eluted in either water or a buffer provided with the kit. Purification can be fully automated on the QIAcube Connect.

Performance

The high-quality viral RNA isolated using the QIAamp Viral RNA Mini Kit performs well in a wide range of downstream applications, including viral genotyping, viral epidemiology, and infectious disease research (see figure "").

See figures

Amplification of RNA from plasma.

Principle

The QIAamp Viral RNA Mini Kit simplifies isolation of viral RNA from cell-free body fluids with fast spin-column or vacuum procedures. No phenol–chloroform extraction is required. Viral RNA binds specifically to the QIAamp silica membrane while contaminants pass through. PCR inhibitors, such as divalent cations and proteins, are completely removed in two efficient wash steps, leaving pure viral RNA to be eluted in either water or a buffer provided with the kit.

QIAamp RNA technology yields viral RNA from cell-free body fluids ready to use in RT-PCR and blotting procedures. QIAamp sample preparation technology is fully licensed.

Procedure

Optimized buffers and enzymes lyse samples, stabilize nucleic acids, and enhance selective RNA adsorption to the QIAamp membrane. To guarantee RNA integrity, samples are lysed under highly denaturing conditions to inactivate RNases. Alcohol is added and lysates loaded onto the QIAamp spin column. Wash buffers are used to remove impurities and pure, ready-to-use RNA is then eluted in water or low-salt buffer.

The QIAamp Viral RNA Mini Kit is automatable on the QIAcube. The QIAamp Viral RNA Mini Accessory Set provides the additional buffers and reagents needed for automated, low-throughput sample prep using both QIAcube and QIAamp Viral RNA Mini Kit.

Vacuum processing

For greater speed and convenience in RNA purification, samples can be processed by vacuum instead of centrifugation. QIAamp Mini spin columns (see figure "QIAamp Viral RNA Mini spin column") are accommodated on the QIAvac 24 manifold using VacValves and VacConnectors, provided in the QIAamp Vac Accessory Set. VacValves should be used if sample flow rates differ significantly, in order to ensure consistent vacuum. Disposable VacConnectors are used to avoid any cross-contamination.

Applications

The QIAamp Viral RNA Mini Kit simplifies purification of viral RNA from cell-free body fluids, offering fast spin-column or vacuum procedures, or automation on QIAcube. Sample types include:

Plasma and serum
CSF
Urine
Other cell-free body fluids
Cell-culture supernatants

Supporting data and figures

Amplification of RNA from plasma.

RT-PCR products of a 1026 nt RNA fragment purified from plasma. Serial tenfold dilutions (as indicated) were added to plasma and purified using the QIAamp Viral RNA Mini Kit. M: markers; C: negative control.

Specifications

Features	Specifications
Applications	PCR, qPCR, real-time PCR
Time per run or per prep	20–40 minutes
Technology	Silica technology
Elution volume	50 µl
Purification of total RNA, miRNA, poly A+ mRNA, DNA or protein	Viral RNA
Processing	Manual (centrifugation or vacuum)
Sample amount	140 µl
Format	Spin columns
Main sample type	Liquid media
Yield	>90% recovery

Resources

Download Safety Data Sheets for QIAGEN product components.

For purification of viral RNA from plasma, serum, cell-free body fluids, cell-culture supernatants

Publications

Mutation of a diacidic motif in SIV-PBj Nef impairs T-cell activation and enteropathic disease.

Tschulena U; Sanzenbacher R; Mühlebach MD; Berger A; Münch J; Schindler M; Kirchhoff F; Plesker R; Coulibaly C; Panitz S; Prüfer S; Muckenfuss H; Hamdorf M; Schweizer M; Cichutek K; Flory E;

Retrovirology; 2011; 8 :14 2011 Mar 2 PMID:21366921

Detection and differentiation of tick-borne encephalitis virus subtypes by a reverse transcription quantitative real-time PCR and pyrosequencing.

Achazi K; Nitsche A; Patel P; Radonić A; Donoso Mantke O; Niedrig M;

J Virol Methods; 2010; 171 (1):34-9 2010 Oct 7 PMID:20933016

Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold.

Eccles R; Meier C; Jawad M; Weinmüllner R; Grassauer A; Prieschl-Grassauer E;

Respir Res; 2010; 11 :108 2010 Aug 10 PMID:20696083

Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.

Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC;

Influenza Other Respir Viruses; 2010; 4 (4):199-204 2010 Jul PMID:20836794

Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Irie T; Nagata N; Igarashi T; Okamoto I; Sakaguchi T;

PLoS One; 2010; 5 (5):e10719 2010 May 19 PMID:20502666

FAQ

Yes, Carrier RNA is available separately. It is sold in combination with other buffers in the QIAamp MinElute Virus Accessory Set and the QIAamp Viral RNA Mini Accessory Set.

In addition, Poly-A Carrier RNA by itself, without any buffers, is offered under the following catalog numbers:

•1017647: 12 vials, each containing 1350 µg lyophilized carrier RNA

•1068337: 1 vial containing 310 µg lyophilized carrier RNA

FAQ ID -351

Yes, please follow the User-Developed Protocol Isolation of viral RNA from stool using the QIAamp Viral RNA Mini Kit .

FAQ ID -918

QIAGEN Proteinase K is a subtilisin-type protease, which cleaves at the carboxyl side of hydrophobic, aliphatic and aromatic amino acids. It is particularly suitable for short digestion times. It possesses a high specific activity over a wide range of temperatures and pH values with substantially increased activity at higher temperature. Soluble calcium is not essential for enzymatic activity. This means that EDTA, which is used to inhibit Mg2+-dependent enzymes such as nucleases, will not inhibit Proteinase K activity.

QIAGEN Protease is a broad-specificity Serine protease with high activity, cleaving preferentially at neutral and acidic residues. It is an economical alternative to Proteinase K for isolation of native DNA and RNA from a variety of samples.

For more information on activity of QIAGEN Protease and Proteinase K in various buffers please click here.

FAQ ID -761

The QIAamp Viral RNA Mini Kit (cat. no. 52904 or 52906) is one of the reagents used worldwide to isolate viral RNA from respiratory samples and is currently also used to detect coronavirus SARS-CoV-2, which causes COVID-19.

During the pandemic, we are focused on ramping up production of the larger kit size QIAamp Viral RNA Mini Kit (250), cat. no. 52906. During this time, the smaller kit size will be unavailable. The two kits are identical in their use and performance.

FAQ ID -147395

Small amounts of RNA and DNA may be difficult to measure spectrophotometrically. Fluorometric measurements, or quantitative RT-PCR and PCR are more sensitive and accurate methods to quantify low amounts of RNA or DNA.

Fluorometric measurements are carried out using nucleic acid binding dyes, such as RiboGreen® RNA Quantitation Reagent for RNA, and PicoGreen® DNA Quantitation Reagent for DNA (Molecular Probes, Inc.).

FAQ ID -728

According to an Interview with Professor Dennis Lo published in QIAGEN News Molecular Diagnostics, Issue No. 5, 2002, healthy individuals have about 500-1000 genome equivalents (DNA) per ml serum/plasma.

For free-circulating DNA in plasma, the concentration can range from 1–100 ng/ml in healthy individuals.

FAQ ID -635

For RNA isolated on the BioRobot EZ1 and BioRobot M48:

The RNA can be directly applied to the Agilent Bioanalyzer, since it is being denatured in the final protocol steps of these isolation procedures.

For RNA prepared with all other QIAGEN RNA Isolation Products:

We recommend to denature the samples in a water bath for 2 min at 70°C, and then place them directly on ice prior to loading them onto the Agilent Bioanalyzer.

FAQ ID -528

Always dispose of potentially biohazardous solutions according to your institution’s waste-disposal guidelines. Although the lysis and binding buffers in QIAamp, DNeasy, and RNeasy kits contain chaotropic agents that can inactivate some biohazardous material, local regulations dictate the proper way to dispose of biohazards. DO NOT add bleach or acidic solutions directly to the sample-preparation waste. Guanidine hydrochloride in the sample-preparation waste can form highly reactive compounds when combined with bleach.
Please access our Material Safety Data Sheets (MSDS) online for detailed information on the reagents for each respective kit.

FAQ ID -12

Country and Language

Contact Us

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

QIAamp Viral RNA Mini Kit

For isolation of viral RNA from cell-free body fluids

Features

Useful Resources

Product Details

Performance

See figures

Principle

Procedure

Vacuum processing

Applications

Supporting data and figures

Amplification of RNA from plasma.

Specifications

Resources

Publications

Mutation of a diacidic motif in SIV-PBj Nef impairs T-cell activation and enteropathic disease.

Detection and differentiation of tick-borne encephalitis virus subtypes by a reverse transcription quantitative real-time PCR and pyrosequencing.

Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold.

Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.

Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

FAQ

Country and Language

Follow Us

Contact Us